Metformin’s Brain Link: New Pathway Behind a 60-Year-Old Diabetes Drug

TL;DR
A Science Advances study in mice shows metformin lowers glucose via brain Rap1 signaling in the ventromedial hypothalamus, not just liver or gut; deleting Rap1 in this brain region abolishes metformin’s effect, while direct brain administration also lowers glucose, suggesting brain-targeted mechanisms could unlock new diabetes therapies and possibly aging benefits.
Want the full story? Read the original reporting
Read on ScienceAlert